Economic assessment of maintenance treatment of recurrent depressive disorder with milnacipran versus episode treatment;Evaluation medico-economique de milnacipran dans la prevention des episodes depressifs

Encephale

Volumn 25, Issue 5, 1999, Pages 401-407

  Lafuma, A ^a   Dardennes, R ^c   Fagnani, F ^a   Pribil, C ^a   Bisserbe, J C ^b   Berdeaux, Gilles ^b  

^a CEMKA EVAL   (France)

^b INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^c NONE

Author keywords

Affective disorder; Antidepressant; Cost effectiveness; Economics; Maintenance treatment; Milnacipran

Indexed keywords

MILNACIPRAN; ANTIDEPRESSANT AGENT; CYCLOPROPANE DERIVATIVE;

ARTICLE; DEPRESSION; DRUG EFFICACY; ECONOMIC ASPECT; HEALTH CARE COST; HOSPITALIZATION; HUMAN; MODEL; RECURRENT DISEASE; ACUTE DISEASE; ADULT; CLINICAL TRIAL; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; FOLLOW UP; FRANCE; MALE; MENTAL HEALTH SERVICE; PROBABILITY; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS; COST-BENEFIT ANALYSIS; CYCLOPROPANES; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; MALE; MARKOV CHAINS; MENTAL HEALTH SERVICES; RECURRENCE; TREATMENT OUTCOME;

EID: 0032710848     PISSN: 00137006     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. ANGST J. How recurrent and predictable is depressive illness ? In : Montgomery SA, Rouillon F, eds. Long-term treatment of depression. Chichester : Wiley, 1992 ; 1-13.
2. ANGST J, KUPFER DJ, ROSENBAUM JF. Recovery from depression : risk or reality ? Acta Psychiatr Scand 1996 ; 93 : 413-9.
3. AVERY D, WINOKUR G. Mortality in depressed patients treated with electroconvulsive therapy and antidepressants, Arch Gen Psychiatry 1976 ; 33 : 1029-37.
4. BISSERBE JC. Evaluation à long terme des traitements des états dépressifs et des troubles anxieux. Therapie 1994 ; 50 : 251-60.
5. BLACK DW, WINOKUR G, MOHANDOSS E et al. Does treatment influence mortality in depressives ? A follow-up of 1076 patients with major affective disorders. Ann Clin Psychiatry 1989 ; 1 : 165-73.
6. BLAIR-WEST GW, MELLSOP GW, EYESON-ANNAN ML. Down-rating lifetime suicide risk in major depression. Acta Psychiatr Scand 1997 ; 95 : 259-63.
7. BLAND RC. Epidemiology of affective disorders : a review. Can J Psychiatry 1997 ; 42 : 367-7.
8. BOYER P, DANION JM, BISSERBE JC et al. Clinical and economic comparison of sertraline and fluoxetine in the treatment of depression. Pharmacoeconomics 1998 ; 13 (1 part 2) : 157-69.
9. CLERY-MELIN P. Des alternatives à l'hospitalisation : pour des soins diversifiés et de qualité en psychiatrie. Rapport de mission auprès du Ministère des Affaires Sociales, de la Santé et de la Ville, janvier 1995.
10. CORYELL W, AKISKAL H, LEON AC et al. The time course of non-chronic major depressive disorder. Arch Gen Psychiatry 1994 ; 51 : 405-10.
11. DARDENNES R, LAFUMA A, BERDEAUX G et al. Milnacipran, antidépresseurs tricycliques ou inhibiteurs spécifiques de la recapture de sérotonine ? Etude comparative coût-efficacité du traitement d'un épisode dépressif. A paraître dans Synapse.
12. DAVIS JM. Maintenance therapy in psychiatry : II - affective disorders. Am J Psychiatry 1976 ; 133 : 1.
13. DEPRESSION GUIDELINE PANEL. Depression in primary care : Volume 2. Treatment of Major Depression. Clinical Practice Guideline, Number 5. Rockville, MD. US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication N° 93-0551, April 1993.
14. FAWCETT J, SHEFTNER W, CLARK D et at. Clinical predictors of suicide in patients with major affective disorders : a controlled prospective study. Am J Psychiatry 1987 ; 144 : 35-40.
15. FRANCK E, KUPFER DJ, PEREL JM et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990 ; 47 : 1093-9.
16. FRANCK E, PRIEN RF, JARRETT RB et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder : remission, recovery, relapse and recurrence. Arch Gen Psychiatry 1991 ; 48 : 851-5.
17. GUZE SB, ROBINS E. Suicide and primary affective disorders. Br J Psychiatry 1970 ; 117 : 437-8.
18. INSKIP HM, HARRIS EC, BARRACLOUGH B. Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. Br J Psychiatry 1998 ; 172 : 35-7.
19. KELLER MB, SHAPIRO RW, LAVORI PW et al. Recovery in major depressive disorder. Arch Gen Psychiatry 1982 ; 39 : 905-10.
20. KILOH LG, ANDREWS G, NEILSON M. The long-term outcome of depressive illness. Br J Psychiatry 1988 ; 153 : 752-7.
21. LEE AS, MURRAY RM. The long-term outcome of Maudsley depressives. Br J Psychiatry 1988 ; 153 : 741-51.
22. MURRAY CJL, LOPEZ AD. In : Murray CJL, Lopez AD, eds. The global burden of disease. Geneva, Switzerland : The Harvard School of Public Health on behalf of the World Health Organization and the World Bank, 1996.
23. PRIEN RF, KOCSIS JH. Long-term management of mood disorders. In : Bloom & Kupfer, eds. Psychopharmacology : The fourth generation in progress. New York : Raven Press, 1995 ; 1067-79.
24. ROUILLON F, MOLES MF, BISSERBE JC et al. A Milnacipran efficacy in the prevention of recurrent depression : a twelve month study. Castres : Study Report, IRPF C230, 1997.
25. SOLOMON DA, KELLER MB, LEON AC et al. Recovery from major depression : A 10-year prospective follow-up across multiple episodes. Arch Gen Psychiatry 1997 ; 54 : 1001-6.
26. SONNENBERG F, BECK R. Markov models in medical decision making - a practical guide. Med Decis Making 1993 ; 13 : 322-38.
27. SURTEES PG, BARKLEY C. Future imperfect : the long-term outcome of depression. Br J Psychiatry 1994 ; 164 : 327-41.
28. THORNICROFT G, SARTORIUS N. The course and outcome of depression in different cultures : 10 year follow-up of the WHO collaborative study on the assessment of depressive disorders. Psychol Med 1993 ; 23 : 1023-32.
29. TOLLEFSON GD, FAWCETT J, WINOKUR G et al. Evaluation of suicidality during pharmacologic treatment of mood and nonmood disorders. Ann Clin Psychiatry 1993 ; 5 : 209-24.
30. WAGNER W, ZABORNY BA, GRAY TE. Fluvoxamine. A review of its safety profile in world-wide studies. Int Clin Psychopharmacol 1994 ; 9 : 223-7.
31. WELLS KB, STURM R, SHERBOURNE CD et al. Caring for depression : a RAND study Cambridge (USA) : Harvard University Press, 1996 ; 252 p.
32. WINOKUR G, CORYELL W, KELLER M et al. A prospective follow-up of patients with bipolar and primary unipolar affective disorder. Arch Gen Psychiatry 1993 ; 50 : 457-65.
33. WORLD HEALTH ORGANIZATION MENTAL HEALTH COLLABORATING CENTRES. Pharmacotherapy of depressive disorders : a consensus statement. J Affect Disord 1989 ; 17 : 197-9.